Namibia
Tuberculosis profile
| High HIV burden |
Population  2012 2.3 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.32 (0.26–0.4) 14 (11–18)
Mortality (HIV+TB only) 1.6 (1.3–2) 70 (56–89)
Prevalence  (includes HIV+TB) 16 (6.1–29) 688 (271–1 295)
Incidence  (includes HIV+TB) 15 (12–18) 655 (524–800)
Incidence (HIV+TB only) 7.3 (5.8–8.9) 323 (258–394)
Case detection, all forms (%) 68 (55–84)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 4 333 (49) Relapse 1 134 (50)
Smear-negative 1 421 (16) Treatment after failure 143 (6)
Smear-unknown / not done 1 052 (12) Treatment after default 133 (6)
Extrapulmonary 2 063 (23) Other 866 (38)
Other          
Total new 8 869   Total retreatment 2 276  
           
Other (history unknown)          
Total new and relapse 10 003   Total cases notified 11 145  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.4 1.3 1.2
Age < 15 142 725 343
Laboratories 2012
Smear (per 100 000 population) 1.4
Culture (per 5 million population) 2.2
Drug susceptibility testing (per 5 million population) 2.2
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 84   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 87  
Retreatment 80  
TB/HIV 2012 Number (%)
TB patients with known HIV status 9 927 (89)
HIV-positive TB patients 4 688 (47)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 4 656 (99)
HIV-positive TB patients on antiretroviral therapy (ART) 3 362 (72)
HIV-positive people screened for TB 12 272  
HIV-positive people provided with IPT 11 906  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 3.8 (2.7–5.1) 16 (13–21)
MDR-TB cases among notified pulmonary
TB cases
260 (190–350) 370 (290–470)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases 30 180 210
Patients started on MDR-TB treatment     288
Financing TB control 2013
National TB programme budget (US$ millions) 37
% Funded domestically 55%
% Funded internationally 29%
% Unfunded 16%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data